J. Goldman & Co LP - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 37 filers reported holding VINCERX PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q1 2022$172,000
-60.8%
43,1010.0%0.01%
-66.7%
Q4 2021$439,000
-70.9%
43,101
-62.9%
0.02%
-59.3%
Q2 2021$1,509,000
+65.6%
116,160
-4.0%
0.06%
+96.7%
Q1 2021$911,000
-35.6%
120,955
-17.0%
0.03%
-58.3%
Q4 2020$1,414,000145,6420.07%
Other shareholders
VINCERX PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,618,199$31,231,00010.26%
Affinity Asset Advisors, LLC 543,010$10,480,0003.56%
ACUTA CAPITAL PARTNERS, LLC 394,000$7,604,0002.74%
TANG CAPITAL MANAGEMENT LLC 500,000$9,650,0002.72%
Logos Global Management LP 480,000$9,264,0000.90%
Sio Capital Management, LLC 105,000$2,027,0000.41%
SABBY MANAGEMENT, LLC 82,948$1,601,0000.31%
Monashee Investment Management LLC 99,999$1,930,0000.30%
Ikarian Capital, LLC 438,684$8,467,0000.28%
RTW INVESTMENTS, LP 500,000$9,650,0000.15%
View complete list of VINCERX PHARMA INC shareholders